A proprietary blend is a group of ingredients on a supplement label that is declared as one total weight, with the ingredients listed in order of predominance but without individual amounts. You will see it as a line like "Energy Matrix 850 mg (taurine, green tea extract, rhodiola root, caffeine)" — one number, four ingredients, no way to know whether the caffeine is 200 mg or 20 mg.
It is legal in the United States. It is also one of the fastest ways to lose a customer who reads labels.
The rule in one paragraph
Under 21 CFR 101.36, a dietary supplement that contains a proprietary blend must declare the total quantity of the blend, list the ingredients in descending order by weight, and may omit the individual amounts. Ingredients that carry an established Daily Value — most vitamins and minerals — generally cannot be folded into a blend and have to be declared on their own line. The blend must still appear in the Supplement Facts panel in the correct position by weight, and everything in it must be a lawful dietary ingredient.
So the label is not lying. It is choosing not to tell you how much of each thing you are getting, within a rule that allows it.
Why brands do it
There are two reasons, and they are not equally respectable.
The legitimate one: formula protection. A small brand with a differentiated blend does not want a competitor to copy the ratios, re-label it, and undercut them on Amazon within a quarter. Keeping the ratios private is a defensible commercial decision, especially for a blend that took months of sensory and stability work to get right.
The other one: it hides underdosing. If a formula contains 50 mg of a clinically studied extract and 800 mg of a cheap bulking agent, a proprietary blend lets both sit behind one number. The label is technically accurate and commercially misleading at the same time. Buyers have learned this, which is why the phrase now reads as a warning to a meaningful share of shoppers.
There is also a middle case that gets ignored: some blends genuinely cannot be dosed individually on a label because the ingredient is a variable extract. A botanical with a specified ratio still varies batch to batch, and the "amount" on the label is a target rather than a fixed quantity. That is a real technical constraint — but it applies to a small number of ingredients, not to the whole catalogue.
What the label actually tells you
Take a typical pre-workout panel:
| Panel line | What it says | What it does not say |
|---|---|---|
| Vitamin B6 2 mg | Exact dose | — |
| Nitric Oxide Blend 3,000 mg | Total weight of four ingredients | How much citrulline vs beetroot |
| Beta-Alanine 2 g | Exact dose | — |
| Energy Blend 450 mg | Total weight of three ingredients | Whether caffeine is 150 mg or 50 mg |
You can calculate the maximum possible dose of any single ingredient in a blend: it cannot exceed the total. That is the only hard limit. Everything else is inference. If the first ingredient listed is caffeine and the blend is 450 mg with three components, caffeine is somewhere under 450 mg and above 150 mg — assuming roughly equal division, which is not guaranteed.
This is why label-reading communities tell people to skip blends entirely and buy single-ingredient products. It is also why some retailers and marketplace quality teams now flag blend-heavy formulas during review.
The commercial cost of hiding doses
Conversion. A shopper comparing two products on a shelf cannot evaluate a blend. When the alternative is a transparent label at a similar price, the blend usually loses, because the shopper cannot tell whether they are getting a deal or a dilution.
Retail listings. Some buyers in the natural channel ask for full disclosure before onboarding, particularly for sports nutrition and weight management. A blend can stop a listing before it starts.
Review risk. The most common one-star review pattern for blend products is not "it didn't work" — it is "I found out it only has 50 mg of the thing I bought it for". That review is permanent and public.
Reformulation cost later. Moving from a blend to full disclosure is not a label edit. It usually means raising the dose of the actives that were carrying the formula, which raises cost per unit, which changes the price, which changes the margin model. Brands that plan for transparency from day one avoid this.
When a blend is actually the right call
There are cases where a blend is defensible, and it is worth naming them because the answer is not "never".
- Flavour and colour systems. Nobody needs to know the ratio of natural flavours, and disclosing it gives away nothing of value to the customer.
- Enzyme complexes. Enzyme activity is measured in units, not milligrams, and the meaningful number is the activity per capsule, which can be declared separately.
- Probiotic blends. Strain-level disclosure is increasingly expected, but the carrier and the blend matrix do not need individual weights.
- Trade-secret botanicals with a proprietary extract. If the extract itself is the IP, a blend with a declared total and a named extract is a reasonable compromise — provided the extract is standardized and the standardization is on the COA.
Notice what these have in common: the blend protects something real, and the customer still gets the information that determines whether the product works.
Three disclosure levels, and what each costs
Most brands end up choosing one of these. The choice should be made before the formula is finalised, because it changes the quote.
1. Full transparency. Every active is declared with a milligram amount. Highest trust, highest COGS, easiest retail onboarding, easiest comparison shopping — which cuts both ways, since competitors can see exactly what you are doing.
2. Anchor dosing. Declare the two or three ingredients that carry the claim, and put the supporting cast in a blend. This is the most common compromise in sports nutrition. It reads as honest as long as the anchor doses are actually meaningful and not 10 mg of a trademarked extract used for the logo.
3. Full blend. One total weight, no individual doses. Cheapest to formulate, hardest to defend, and increasingly hard to sell to anyone who reads the back of the bottle.
If you are launching on a marketplace with heavy price competition, option 3 will look attractive for about six months. After that, the reviews catch up.
What changing the label actually involves
Moving from a blend to disclosure is a formulation project, not a design project. In practice it runs in this order:
- Audit the current formula. Work out the real dose of each active, not the target. Blends often hide the fact that one ingredient is at 30% of the studied dose.
- Decide which actives carry the claim. Those get real doses. The rest can stay in a supporting blend or be cut.
- Re-cost the formula. Raising a dose by 4x is not a rounding error. This is where most transparency projects die.
- Check the physical fit. A bigger dose may not fit the capsule size, the gummy piece weight, or the stick pack. A 3 g gummy can only carry so much.
- Re-run stability. More actives means more interactions, more moisture sensitivity, more risk of off-notes over 24 months.
- Update the label for each market. The US rule and the EU rule are not identical, and a blend that is acceptable in one market may not be in another.
- Reissue the COA template. Individual assay results per active, not just a total.
That is 6 to 10 weeks of work before a single unit is made, which is why it should be planned alongside the first production run rather than after a bad review.
What we do when a brand brings us a blend
Most brands arrive with a formula built somewhere else and a label that hides the doses. The first thing we do is ask for the actual weights, not the label. Then we check three things: whether the anchor ingredient is at a dose that matches the claim, whether the blend fits the delivery format, and whether the cost model survives disclosure.
If the answer to the first question is no, the honest advice is to fix the formula before spending money on packaging. A transparent label on an underdosed product is worse than a blend, because now the customer can see the problem.
Our standard MOQ is 1,000 units per SKU, production runs 4 to 6 weeks after artwork approval, and we quote the transparent version and the blend version side by side so the cost difference is visible before you commit. Sometimes the difference is smaller than brands expect. Sometimes it is the reason the blend existed in the first place.
Either way, you should know which one you are looking at.
FAQ
Is a proprietary blend legal?
Yes, in the United States. 21 CFR 101.36 allows a blend to declare total weight and ingredient order without individual amounts. It is restricted, not banned.
Does a proprietary blend have to list ingredients?
Yes. The ingredients must be listed in descending order by weight. What can be omitted is the individual quantity of each.
Can vitamins and minerals go into a proprietary blend?
Generally no. Ingredients with an established Daily Value have to be declared individually on their own line.
Why do brands use proprietary blends?
Two reasons: protecting a formula from being copied, and avoiding disclosure of small doses. Both are common. Only the first is a good reason.
Is a transparent label worth the extra cost?
If you sell to people who compare labels, yes. If you sell purely on price to buyers who do not read the panel, the maths is different — but that customer base is shrinking.
Can I switch from a blend to full disclosure later?
Yes, but it is a reformulation project: re-dosing, re-costing, stability, and new labels for each market. Budget 6 to 10 weeks before production.
Reviewed by Dr. Xu Wei, PhD, formulation scientist at ZOOMSHEAL in Guangzhou (23 years of supplement contract manufacturing). Last updated: November 2026. This article is for educational purposes and does not replace medical advice.






